Contreras G , Roth D , Pardo V , Striker LG , Schultz DR.Lupus nephritis: a clinical review for practicing nephrologists . Clin Nephrol2002; 57: 95-107 .
2.
Karim Y , D’Cruz DP . The NIH pulse cyclophosphamide regime: the end of an era? Lupus2004; 13: 1-3 .
3.
Chan TM , Li FK , Tang CSet al.Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group . N Engl J Med2000; 343: 1156-1162 .
4.
Austin HA 3rd , Klippel JH , Balow JEet al.Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs . N Engl J Med1986; 314: 614-619 .
5.
Boumpas DT , Austin HA 3rd , Vaughn EMet al.Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis . Lancet1992; 340: 741-745 .
6.
Gourley MF , Austin HA 3rd , Scott Det al.Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial . Ann Intern Med1996; 125: 549-575 .
7.
Illei GG , Austin HA , Crane Met al.Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis . Ann Intern Med2001; 135: 248-257 .
8.
Flanc RS , Roberts MA , Strippoli GF , Chadban SJ , Kerr PG , Atkins RC.Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials . Am J Kidney Dis2004; 43: 197-208 .
9.
El Hachmi M , Jadoul M , Lefebvre C , Depresseux G , Houssiau FA.Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome . Lupus2003; 12: 692-696 .
10.
Houssiau FA , Vasconcelos C , D’Cruz Det al.Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide . Arthritis Rheum2002; 46: 2121-2131 .
11.
Fraenkel L , Bogardus S , Concato J.Patient preferences for treatment of lupus nephritis . Arthritis Rheum2002; 47: 421-428 .
12.
Houssiau FA , D’Cruz DP , Haga HJ , Hughes GR.Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: a preliminary study . Lupus1991; 1: 31-35 .
13.
Martin-Suarez I , D’Cruz D , Mansoor M , Fernandes AP , Khamashta MA , Hughes GR.Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide . Ann Rheum Dis1997; 56: 481-487 .
14.
Haga HJ , D’Cruz D , Asherson R , Hughes GR.Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis . Ann Rheum Dis1992; 51: 885-888 .
15.
Ioannidis JP , Boki KA , Katsorida ME.Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide . Kidney Int2000; 57: 258-264 .
16.
Ginzler EM , Aranow C , Buyon J.A multicenter study of mycophenolate mophetil (MMF) vs. intravenous cyclophosphamide (CYC) as induction therapy for severe lupus nephritis (LN): preliminary results . Arthritis Rheum2003; 48: S1690-S1690 .
17.
Ginzler EM , Aranow C , Merrill JT , Orloff K , Henry D.Toxicity and tolerability of mycophenolate mofetil (MMF) vs. intravenous cyclophosphamide (CYC) in a multicenter trial as induction therapy for lupus nephritis (LN) . Arthritis Rheum2003; 48: S1515-S1515 .
18.
Contreras G , Pardo V , Leclercq Bet al.Sequential therapies for proliferative lupus nephritis . N Engl J Med2004; 350: 971-980 .
19.
Ferro ML , Karim MY , Abbs IC , D’Cruz D , Khamashta MA , Hughes GRV.Mycophenolate mofetil: a potential treatment for reducing proteinuria associated with membranous lupus nephritis . Arthritis Rheum2003; 48: S1520-S1520 .
20.
Karim MY , Alba P , Cuadrado MJet al.Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents . Rheumatology (Oxford)2002; 41: 876-882 .
21.
Bijl M , Horst G , Bootsma H , Limburg PC , Kallenberg CG.Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk . Ann Rheum Dis2003; 62: 534-539 .
